A selective thromboxane A2 (TXA2) synthase inhibitor, ozagrel, attenuates lung injury and decreases monocyte chemoattractant protein-1 and interleukin-8 mRNA expression in oleic acid-induced lung injury in guinea pigs. (Q43270585)
Jump to navigation
Jump to search
scientific article published on 26 September 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | A selective thromboxane A2 (TXA2) synthase inhibitor, ozagrel, attenuates lung injury and decreases monocyte chemoattractant protein-1 and interleukin-8 mRNA expression in oleic acid-induced lung injury in guinea pigs. |
scientific article published on 26 September 2009 |
Statements
A selective thromboxane A2 (TXA2) synthase inhibitor, ozagrel, attenuates lung injury and decreases monocyte chemoattractant protein-1 and interleukin-8 mRNA expression in oleic acid-induced lung injury in guinea pigs (English)
Hiroshi Moriuchi
Yoichiro Isohama
Hidehiro Tokunaga
Keita Hatamoto
Sumika Kurita
Mitsuru Irikura
Ken-ichi Iyama
26 September 2009